Balchem Co. (NASDAQ:BCPC) Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC lifted its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 10.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,060 shares of the basic materials company's stock after buying an additional 5,045 shares during the period. ProShare Advisors LLC owned approximately 0.16% of Balchem worth $8,649,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Congress Asset Management Co. lifted its holdings in shares of Balchem by 5.4% during the fourth quarter. Congress Asset Management Co. now owns 317,610 shares of the basic materials company's stock worth $51,769,000 after purchasing an additional 16,170 shares during the period. Apollon Wealth Management LLC purchased a new position in Balchem during the 4th quarter worth approximately $503,000. Charles Schwab Investment Management Inc. lifted its stake in Balchem by 2.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 370,912 shares of the basic materials company's stock valued at $60,457,000 after acquiring an additional 8,942 shares during the period. Tributary Capital Management LLC boosted its holdings in shares of Balchem by 1.2% in the 4th quarter. Tributary Capital Management LLC now owns 136,255 shares of the basic materials company's stock valued at $22,209,000 after acquiring an additional 1,634 shares during the last quarter. Finally, Annex Advisory Services LLC increased its stake in shares of Balchem by 35.4% in the fourth quarter. Annex Advisory Services LLC now owns 7,496 shares of the basic materials company's stock worth $1,222,000 after acquiring an additional 1,959 shares during the period. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Balchem Stock Performance

Shares of NASDAQ BCPC traded down $1.16 during midday trading on Friday, reaching $166.39. 13,754 shares of the stock were exchanged, compared to its average volume of 137,150. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The firm has a market cap of $5.43 billion, a price-to-earnings ratio of 42.38, a PEG ratio of 4.41 and a beta of 0.93. The firm has a 50-day simple moving average of $161.80 and a two-hundred day simple moving average of $166.34. Balchem Co. has a twelve month low of $145.70 and a twelve month high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The firm had revenue of $250.52 million for the quarter, compared to analysts' expectations of $245.70 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the company posted $1.03 earnings per share. As a group, analysts anticipate that Balchem Co. will post 4.64 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on BCPC shares. HC Wainwright set a $180.00 target price on shares of Balchem and gave the company a "buy" rating in a research report on Monday, April 28th. Wall Street Zen cut Balchem from a "buy" rating to a "hold" rating in a report on Wednesday. Finally, Sidoti upgraded Balchem to a "hold" rating in a research note on Tuesday, February 25th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.